Cargando…

Differences in epitope‐specific antibodies to pertussis toxin after infection and acellular vaccinations

OBJECTIVES: Pertussis toxin (PT) is a component of all acellular pertussis vaccines. PT must be detoxified to be included in acellular vaccines, which results in conformational changes in the functional epitopes of PTs. Therefore, induced epitope‐specific antibodies to PT may vary after vaccinations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knuutila, Aapo, Dalby, Tine, Barkoff, Alex‐Mikael, Jørgensen, Charlotte Sværke, Fuursted, Kurt, Mertsola, Jussi, Markey, Kevin, He, Qiushui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396262/ https://www.ncbi.nlm.nih.gov/pubmed/32765879 http://dx.doi.org/10.1002/cti2.1161

Ejemplares similares

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
por: Knuutila, Aapo, et al.
Publicado: (2023)

Simultaneous Determination of Antibodies to Pertussis Toxin and Adenylate Cyclase Toxin Improves Serological Diagnosis of Pertussis
por: Knuutila, Aapo, et al.
Publicado: (2021)

Pertussis toxin neutralizing antibody response after an acellular booster vaccination in Dutch and Finnish participants of different age groups
por: Knuutila, Aapo, et al.
Publicado: (2022)

Evaluation of Anti-PT Antibody Response after Pertussis Vaccination and Infection: The Importance of Both Quantity and Quality
por: Barkoff, Alex-Mikael, et al.
Publicado: (2021)

Multiplex Point-of-Care Tests for the Determination of Antibodies after Acellular Pertussis Vaccination
por: Knuutila, Aapo, et al.
Publicado: (2020)

Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants
por: Knuutila, Aapo, et al.
Publicado: (2023)

Macrolide Resistance in Bordetella pertussis: Current Situation and Future Challenges
por: Ivaska, Lauri, et al.
Publicado: (2022)

Lack of Association between Mannose Binding Lectin and Antibody Responses after Acellular Pertussis Vaccinations
por: Gröndahl-Yli-Hannuksela, Kirsi, et al.
Publicado: (2014)

Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015
por: Barkoff, Alex-Mikael, et al.
Publicado: (2019)

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
por: Markey, Kevin, et al.
Publicado: (2019)

Antibody Specificity Following a Recent Bordetella pertussis Infection in Adolescence Is Correlated With the Pertussis Vaccine Received in Childhood
por: Raeven, René H. M., et al.
Publicado: (2019)

Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence
por: Mooi, Frits R., et al.
Publicado: (2009)

Bordetella pertussis, Finland and France
por: Caro, Valérie, et al.
Publicado: (2006)

Molecular characterization and epidemiology of Streptococcus pneumoniae serotype 8 in Denmark
por: Hansen, Camilla Bülow, et al.
Publicado: (2021)

Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries
por: Versteegen, Pauline, et al.
Publicado: (2022)

Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom
por: Versteegen, Pauline, et al.
Publicado: (2021)

Corrigendum to ‘Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom’
por: Versteegen, Pauline, et al.
Publicado: (2021)

Infantile Pertussis Rediscovered in China
por: Wang, Jingmin, et al.
Publicado: (2002)

Bordetella pertussis Isolates, Finland
por: Mäkinen, Johanna, et al.
Publicado: (2005)

Nasopharyngeal Bacterial Colonization and Gene Polymorphisms of Mannose-Binding Lectin and Toll-Like Receptors 2 and 4 in Infants
por: Vuononvirta, Juho, et al.
Publicado: (2011)

Bordetella pertussis isolates in Finland: Serotype and fimbrial expression
por: Heikkinen, Eriikka, et al.
Publicado: (2008)

Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
por: Esposito, Susanna, et al.
Publicado: (2019)

Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization
por: Acquaye-Seedah, Edith, et al.
Publicado: (2018)

Comparative Genomics of Bordetella pertussis Reveals Progressive Gene Loss in Finnish Strains
por: Heikkinen, Eriikka, et al.
Publicado: (2007)

Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease among 948,263 individuals ≥ 65 years of age: a Danish cohort study
por: Nielsen, Katrine Finderup, et al.
Publicado: (2022)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
por: Ausiello, Clara Maria, et al.
Publicado: (2014)

Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries
por: Berbers, Guy, et al.
Publicado: (2021)

The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies
por: Abu-Raya, Bahaa, et al.
Publicado: (2019)

Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccination
por: van Schuppen, Evi, et al.
Publicado: (2022)

Epidemiology of pertussis in Denmark, 1995 to 2013
por: Dalby, Tine, et al.
Publicado: (2016)

Acellular Pertussis Vaccine Components: Today and Tomorrow
por: Dewan, Kalyan K., et al.
Publicado: (2020)

Pertussis outbreak in university students and evaluation of acellular pertussis vaccine effectiveness in Japan
por: Hara, Megumi, et al.
Publicado: (2015)

The seroepidemiology of Immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study
por: Zhang, Qi, et al.
Publicado: (2012)

Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines
por: Zomer, Aldert, et al.
Publicado: (2018)

Burden of Children Hospitalized With Pertussis in Canada in the Acellular Pertussis Vaccine Era, 1999–2015
por: Abu-Raya, Bahaa, et al.
Publicado: (2018)

Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice
por: Holubová, Jana, et al.
Publicado: (2020)

Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine
por: Decker, Michael D., et al.
Publicado: (2015)

Tetanus–diphtheria–acellular pertussis vaccination for adults: an update
por: Lee, Hyo-Jin, et al.
Publicado: (2017)

Proteomics of Bordetella pertussis whole-cell and acellular vaccines
por: Möller, Jens, et al.
Publicado: (2019)

Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy
por: Alghounaim, Mohammad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8tmg90jldnhh2puakjq9l359jl